Volume 30, Number 4—April 2024
Research
Bus Riding as Amplification Mechanism for SARS-CoV-2 Transmission, Germany, 20211
Table 1
Main characteristics of case-patients in COVID-19 outbreak, by age group, Hesse, Germany, 2021*
Characteristic | Age, y |
Overall no. (%), n = 191 |
||||||
---|---|---|---|---|---|---|---|---|
<6, no. (%), n = 11 | 6–10, no. (%), n = 73 | 11–17, no. (%), n = 28 | 18–40, no. (%), n = 20 | 41–60, no. (%), n = 30 | >60, no. (%), n = 29 | |||
Sex | ||||||||
F | 5 (45.5) | 32 (43.8) | 14 (50.0) | 14 (70.0) | 13 (43.3) | 18 (62.1) | 96 (50.3) | |
M |
6 (54.5) |
41 (56.2) |
14 (50.0) |
6 (30.0) |
17 (56.7) |
11 (37.9) |
95 (49.7) |
|
Setting | ||||||||
Household | 7 (63.6) | 5 (6.8) | 18 (64.3) | 19 (95.0) | 27 (90.0) | 9 (31.0) | 85 (44.5) | |
Bus | 3 (27.3) | 46 (63.0) | 3 (10.7) | 0 | 1 (3.3) | 6 (20.7) | 59 (30.9) | |
School | 0 | 19 (26.0) | 1 (3.6) | 0 | 0 | 0 | 20 (10.5) | |
Workplace | 0 | 0 | 0 | 0 | 2 (6.7) | 4 (13.8) | 6 (3.1) | |
Travel | 0 | 0 | 0 | 0 | 0 | 5 (17.2) | 5 (2.6) | |
Other | 1 (9.1) | 0 | 2 (7.1) | 1 (5.0) | 0 | 4 (13.8) | 8 (4.2) | |
Unknown |
0 |
3 (4.1) |
4 (14.3) |
0 |
0 |
1 (3.4) |
8 (4.2) |
|
Prior SARS-CoV-2 infection | ||||||||
Yes | 0 | 1 (1.4) | 0 | 0 | 0 | 0 | 1 (0.5) | |
No |
11 (100) |
72 (98.6) |
28 (100) |
20 (100) |
30 (100) |
29 (100) |
190 (99.5) |
|
Symptomatic infection | ||||||||
Yes | 7 (63.6) | 62 (84.9) | 23 (82.1) | 20 (100) | 26 (86.7) | 22 (75.9) | 160 (83.8) | |
No | 4 (36.4) | 11 (15.1) | 5 (17.9) | 0 | 4 (13.3) | 6 (20.7) | 30 (15.7) | |
Value missing |
0 |
0 |
0 |
0 |
0 |
1 (3.4) |
1 (0.5) |
|
Severity of disease, most severe status selected | ||||||||
No treatment | 9 (81.8) | 58 (79.5) | 14 (50.0) | 12 (60.0) | 17 (56.7) | 15 (51.7) | 125 (65.4) | |
Outpatient treatment | 0 | 6 (8.2) | 0 | 3 (15.0) | 5 (16.7) | 0 | 14 (7.3) | |
Inpatient treatment | 0 | 0 | 1 (3.6) | 1 (5.0) | 0 | 3 (10.3) | 5 (2.6) | |
Treatment in ICU | 0 | 0 | 0 | 0 | 2 (6.7) | 0 | 2 (1.0) | |
Deceased | 0 | 0 | 0 | 0 | 0 | 4 (13.8) | 4 (2.1) | |
Value missing |
2 (18.2) |
9 (12.3) |
13 (46.4) |
4 (20.0) |
6 (20.0) |
7 (24.1) |
41 (21.5) |
|
COVID-19 vaccination status | ||||||||
Fully vaccinated | 0 | 0 | 0 | 10 (50.0) | 14 (46.7) | 19 (65.5) | 43 (22.5) | |
Not or not fully vaccinated | 11 (100) | 73 (100) | 28 (100) | 10 (50.0) | 16 (53.3) | 10 (34.5) | 148 (77.5) |
*The variable on severity of disease combines information from the routine surveillance system with survey results, resulting in a high number of missing values. ICU, intensive care unit.
1Preliminary results from this study were presented at the ESCAIDE conference; November 24, 2022; Stockholm, Sweden.
2These first authors contributed equally to this article.
3These senior authors contributed equally to this article.